Mare Activators are a diverse set of chemical compounds that indirectly enhance the functional activity of Mare through targeted modulation of intracellular signaling pathways. Forskolin, by stimulating adenylate cyclase, and IBMX, by inhibiting phosphodiesterases, both serve to elevate intracellular cAMP levels, which in turn activate protein kinase A (PKA). Activated PKA has the potential to phosphorylate Mare, leading to its enhanced activity. Similarly, Ionomycin and A23187, as calcium ionophores, raise intracellular calcium levels, which can activate calcium/calmodulin-dependent kinases, possibly resulting in the phosphorylation and activation of Mare. Phorbol 12-myristate 13-acetate (PMA) directly stimulates protein kinase C (PKC), which may also phosphorylate and activate Mare, provided that Mare is a PKC substrate.
In addition, certain inhibitors such as EGCG, LY294002, U0126, and SB203580 can indirectly promote Mare activation by mitigating inhibitory influences or shifting the balance of cellular signaling in favor of Mare activation. EGCG acts as a broad kinase inhibitor, potentially alleviating negative regulation of Mare, whereas LY294002, a PI3K inhibitor, U0126, a MEK inhibitor, and SB203580, a p38 MAP kinase inhibitor, each can redirect signaling cascades towards pathways that activate Mare. Capsaicin and Zaprinast further contribute to the pool of Mare activators by enhancing calcium signaling and cGMP signaling, respectively, which could lead to Mare activation. Lastly, BAPTA-AM, a calcium chelator, indirectly influences Mare activity by perturbing calcium homeostasis, potentially triggering compensatory signaling mechanisms that activate Mare. Collectively, these chemicals exemplify the intricate network of cellular signaling that can be leveraged to enhance the activity of Mare.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, enzymes that break down cAMP. By preventing cAMP degradation, IBMX indirectly increases cAMP levels, which can enhance PKA activity and subsequently Mare activity if Mare is a PKA substrate. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium can activate calcium/calmodulin-dependent protein kinases, which may in turn enhance the activity of Mare if it is regulated by calcium-dependent phosphorylation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol (DAG) analog that activates protein kinase C (PKC). Activation of PKC can lead to phosphorylation and activation of Mare if Mare is a PKC substrate. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a known inhibitor of certain protein kinases. By inhibiting competing kinases, it may relieve negative regulation on Mare, thereby enhancing its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. By inhibiting PI3K, it may lead to alterations in downstream signaling pathways that could result in the enhanced activity of Mare if Mare functions downstream of PI3K signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK, part of the MAPK/ERK pathway. Inhibition of MEK could shift signaling dynamics in favor of other pathways that activate Mare. | ||||||